Human papillomavirus-related oropharyngeal squamous cell carcinoma (HPV-OPSCC) is considered a disease of comparatively younger patients with the highest incidence among middle-aged men.
Results | The study population comprised 1068 patients with OPSCC, including 954 (89.3%) HPV-positive and 114 (10.7%) HPV-negative tumors (Table) . The HPV-positive patients were younger than HPV-negative patients overall (mean [SD] , 56.9 [9.4] vs 63.1 [13.1] years) and when stratified by time, with the exception of the earliest period of 2002-2007, for which there were only 11 HPV-negative patients (Table) .
Mean age increased for HPV-positive (β = 0.60 years of age per calendar year; 95% CI, 0.41-0.78) and HPV-negative (β = 1.62; 95% CI, 0.88-2.37) patients ( Figure) . For HPVpositive patients, mean age was 51.6 (8.9) years during 2002-2007, increasing to 58.5 (9. 2) years in 2014-2017. For HPVnegative patients, mean age increased from 48.7 (17.2) years during 2002-2007 to 66.4 (11. 3) years in 2014-2017 (Table) . In a sensitivity analysis excluding the 110 tumors tested prior to 2008, these trends remained significant for both HPVpositive (β = 0.38; 95% CI, 0.14-0.62) and HPV-negative (β = 1.02; 95% CI, 0.15-1.91) groups.
Maximum age also significantly increased over the study period for both HPV-positive (β = 1.6; 95% CI, 0.7 to 2.4) and HPVnegative (β = 2.9; 95% CI, 0.8 to 5.1) patients ( Figure) . Minimum age remained stable for both groups (HPV-positive: β = 0.04; 94% CI, −0.4 to 0.5; HPV-negative: β = 0.8; 95% CI, −0.5 to 2.1). Discussion | The age of patients with both HPV-positive and HPVnegative OPSCCs is increasing at our tertiary academic referral center. While the generalizability of a single-center cohort is limited and may be subject to the influences of referral bias, our findings are consistent with a recent analysis of SEER data that showed an increasing incidence in OPSCC among older men in the United States. 2 Despite the unavailability of HPV status in the SEER data, this trend has been attributed to HPV.
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Our findings, however, indicate that OPSCC in the elderly population is not restricted to HPV-related disease. Both HPVpositive and HPV-negative cohorts are affected by the aging of the US population. Examining the rising age of patients with HPV-OPSCC may help to shed light on complex behavioral and biological interactions that underlay HPV exposure, persistent infection, and HPV-driven tumorigenesis. The aging of patients with HPV-OPSCC, for example, may to some degree reflect a birth cohort effect of increasing cultural acceptability of sexual behaviors associated with HPV-OPSCC. 4 Whatever the reasons, HPV-OPSCC should not be regarded as a disease of the relatively young: nearly 10% of the cases occurred in patients aged 70 years or older.
With the population of elderly individuals expected to increase significantly over the next several decades, 4 clinicians will be increasingly faced with complexities of treating an aging population with OPSCC. 5 Consideration of age will be critical when shaping treatment strategies. Patients' HPV status should be grounded in HPV testing and not assumptions based on patient age. 
